Logo-ajpr
Submitted: 13 Mar 2023
Revision: 11 Apr 2023
Accepted: 20 May 2023
ePublished: 30 Jun 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Avicenna J Pharm Res. 2023;4(1): 27-30.
doi: 10.34172/ajpr.1092
  Abstract View: 167
  PDF Download: 6

Original Article

Examining the Consumption Pattern of Three Expensive Antibiotics (Meropenem, Ciprofloxacin, and Cefepime) Before and During the COVID-19 Pandemic in Shahid Beheshti Hospital, Hamadan-Iran

Faezeh Dehnavi 1, Maryam Rangchian 2 ORCID logo, Maryam Etminaniesfahani 2*

1 Hamadan University of Medical Sciences, Pharmacy School, Hamadan, Iran
2 Pharmacy School of Hamadan University of Medical Sciences, Department of Clinical Pharmacy, Hamadan, Iran
*Corresponding Author: Maryam Etminaniesfahani, Email: maryam_etminani@yahoo.com

Abstract

Background: Antibiotic resistance is a global challenge, and information on antibiotic usage is required to combat this issue. The aim of this study was to investigate the consumption pattern of three expensive antibiotics (meropenem, ciprofloxacin, and cefepime) in Shahid Beheshti Hospital, Hamadan.

Methods: All patients who were admitted to Shahid Beheshti Hospital in Hamadan, Iran, in the first 6 months of 2019 as the period before the COVID-19 epidemic and the first 6 months of 2021 as the period during the epidemic and after hospitalization, entered this retrospective cross-sectional study. They received meropenem, ciprofloxacin, and cefepime for treatment and underwent examination. The obtained data were analyzed using SPSS software.

Results: Overall, 213 (35.2%), 270 (34.2%), and 187 (30.6%) patients received meropenem, cefepime, and ciprofloxacin, respectively. In 2.5% of cases, the selected antibiotic was appropriate considering the type of identified microorganism, while in 10.9% and 86.6% of cases, it was wrong or not tested, respectively. The sites of infection for the patients were bacteremia (n=2, 0.3%), coronary artery catheter (n=3, 0.5%), kidney and bladder (n=14, 2.3%), and skin and soft tissue (n=1, 0.2%).

Conclusion: Based on the results, for most cases receiving three expensive antibiotics (meropenem, ciprofloxacin, and cefepime) in Shahid Beheshti Hospital in Hamadan before and during the COVID-19 epidemic, it is impossible to judge if the prescription has been rational or not.



Please cite this article as follows: Dehnavi F, Rangchian M, Etminaniesfahani M. Examining the consumption pattern of three expensive antibiotics (Meropenem, Ciprofloxacin, and Cefepime) before and during the COVID-19 pandemic in Shahid Beheshti hospital, Hamadan-Iran. Avicenna J Pharm Res. 2023; 4(1):27-30. doi:10.34172/ajpr.1092
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 168

Your browser does not support the canvas element.


PDF Download: 6

Your browser does not support the canvas element.